Intel Corporation vs Bristol-Myers Squibb
Side-by-side earnings signal comparison from SEC quarterly filings
Verdict
Intel Corporation (INTC) carries a "Neutral" signal with +2.2% revenue growth, while Bristol-Myers Squibb (BMY) is "Neutral" with -3.4% revenue growth. Both companies report in the Technology and Healthcare sectors.
| Metric | Intel Corporation (INTC) | Bristol-Myers Squibb (BMY) |
|---|---|---|
| Operator Signal | Neutral | Neutral |
| Signal Confidence | HIGH | HIGH |
| Latest Revenue | $13.6B | $11.5B |
| Revenue Growth | 2.2%* | -3.4% |
| Latest EPS | $-0.73 | $1.31* |
| EPS Growth | N/A | 118.3% |
| Sector | Technology | Healthcare |
| Quarters Tracked | 8 | 8 |
Intel Corporation (INTC) carries a "Neutral" signal with +2.2% revenue growth, while Bristol-Myers Squibb (BMY) is "Neutral" with -3.4% revenue growth. Both companies report in the Technology and Healthcare sectors.
Explore More
Related Comparisons
Technology peer
Technology peer
Technology peer
Technology peer
Healthcare peer
Healthcare peer
Healthcare peer
Healthcare peer
The side-by-side above pulls the SEC EDGAR 8-K filings data for both entity A and entity B. What follows is the interpretation — which specific axes carry the most weight for entity A versus entity B, and which differences are large enough to influence a real decision.
Practical use of the comparison: read the data above, then drill into the individual entity A and entity B detail pages for the underlying breakdown. A pairwise comparison answers the relative question; the per-entity pages answer the absolute question.
Source: SEC EDGAR 10-K filings, 2026.